Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
Authors:
- Line NilsenLNLine Nilsen
- Anne FangbergetAFAnne Fangberget
- Oliver GeierOGOliver Geier
- Dag Rune OlsenDODag Rune Olsen
- Therese SeierstadTSTherese Seierstad
- 1 January 2010
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 49 (3) , 354-360
Abstract
Background. For patients with locally advanced breast cancer (LABC) undergoing neoadjuvant chemotherapy (NACT), the European Guidelines for Breast Imaging recommends magnetic resonance imaging (MRI) to be performed before start of NACT, when half of the NACT has been administered and prior to surgery. This is the first study addressing the value of flow-insensitive apparent diffusion coefficients (ADCs) obtained from diffusion-weighted (DW) MRI at the recommended time points for pretreatment prediction and monitoring of treatment response. Materials and methods. Twenty-five LABC patients were included in this prospective study. DW MRI was performed using single-shot spin-echo echo-planar imaging with b-values of 100, 250 and 800 s/mm2 prior to NACT, after four cycles of NACT and at the conclusion of therapy using a 1.5 T MR scanner. ADC in the breast tumor was calculated from each assessment. The strength of correlation between pretreatment ADC, ADC changes and tumor volume changes were examined using Spearman’s rho correlation test. Results. Mean pretreatment ADC was 1.11 ± 0.21 × 10–3 mm2/s. After 4 cycles of NACT, ADC was significantly increased (1.39 ± 0.36 × 10–3 mm2/s; p=0.018). There was no correlation between individual pretreatment breast tumor ADC and MR response measured after four cycles of NACT (p=0.816) or prior to surgery (p=0.620). Conclusion. Pretreatment tumor ADC does not predict treatment response for patients with LABC undergoing NACT. Furthermore, ADC increase observed mid-way in the course of NACT does not correlate with tumor volume changes.Keywords
This publication has 24 references indexed in Scilit:
- Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and RecommendationsNeoplasia, 2009
- Neoadjuvant chemotherapy for locally advanced breast cancer: A review of the literature and future directionsEuropean Journal of Surgical Oncology, 2009
- Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapyNature Clinical Practice Oncology, 2008
- Prospective Early Response Imaging Biomarker for Neoadjuvant Breast Cancer ChemotherapyClinical Cancer Research, 2007
- Diffusion changes precede size reduction in neoadjuvant treatment of breast cancerMagnetic Resonance Imaging, 2006
- Diffusion imaging for evaluation of tumor therapies in preclinical animal modelsMagnetic Resonance Materials in Physics, Biology and Medicine, 2004
- Early Increases in Breast Tumor Xenograft Water Mobility in Response to Paclitaxel Therapy Detected by Non-Invasive Diffusion Magnetic Resonance ImagingNeoplasia, 1999
- In vivo measurement of diffusion and pseudo-diffusion in skeletal muscle at rest and after exerciseMagnetic Resonance Imaging, 1995
- Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.Radiology, 1988
- MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders.Radiology, 1986